Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

Insurers Say More Evidence Needed for
Significant Resource Push Behind PGx

[December 19, 2007]

By Turna Ray

Insurers at a recent conference said they are still seeking more evidence to determine whether genomic-based personalized medicine incurs cost savings before heavily investing in such new technologies.

Login | Subscribe